Background
==========

Mechanical ventilation (MV) is a lifesaving supportive management approach for patients with acute respiratory failure. However, prolonged MV decreases the force-generating capacity of the diaphragm, known as ventilator-induced diaphragmatic dysfunction (VIDD). VIDD increases the risk of difficulty in weaning patients off ventilator support ([@B38]). The effects of MV on muscle function are well studied in adult animal models. However, whilst the underlying mechanisms are incompletely understood, VIDD is associated with muscle fiber remodeling, abnormal diaphragmatic protein turnover (decreased protein synthesis, increased proteolysis, or both), and oxidative injury ([@B33], [@B32]; [@B22], [@B25]).

Preterm infants have reduced diaphragm contractility compared to their term gestation counterparts ([@B10]; [@B17]). Diaphragm fiber type analysis across a number of species indicates a low content of slow Type I (fatigue resistant) muscle fibers in the immature diaphragm (\<10% at birth) versus a higher content in the mature diaphragm (∼50--60%) ([@B16]; [@B18]). In humans, adult proportions of Type I fibers are not attained until 1 y of postnatal age ([@B16]). Neonatal rat diaphragm has a high proportion of fast Type II fibers, which is more susceptible than Type I fibers to muscle atrophy driven by catabolic signaling ([@B8]). Additionally our previous data show a significant increase in reactive oxygen species (ROS) production in lamb diaphragm on initiation of air breathing ([@B37]): the increase in ROS is likely a result of exposure to higher oxygen concentration than experienced in the hypoxic *in utero* environment, and immature development of the antioxidant defensive system. Therefore, preterm infants may be more susceptible to VIDD compared with term or adult subjects, owing to differences in fiber-type composition ([@B16]; [@B17]) and oxidative capacity ([@B37]).

Retinoids are important regulators of differentiation and cell proliferation and play a fundamental role in diaphragm development. Retinoic acid (RA), an irreversibly oxidized form of vitamin A (retinol), has important hormone-like growth factor effect on tissues, including muscles. Vitamin A deficiency decreases the rate of protein synthesis in rat skeletal muscle ([@B20]). Vitamin A deficiency also alters expression of contractile proteins ([@B13]), increasing expression of fast myosin heavy chain (MHC) isoforms by 800% in preterm neonates, and paradoxically, decreasing fast myosin by 50% in one day old neonates ([@B13]). An increase in fast twitch characteristics of the diaphragm of preterm neonates could make the diaphragm more susceptible to fatigue and prone to contraction-induced damage and dysfunction. Importantly, vitamin A deficiency also contributes to development of bronchopulmonary dysplasia (BPD), the chronic respiratory impairment associated with preterm birth, and failed alveolarisation, the incidence of which is linked to duration of MV ([@B7]). Vitamin A supplementation reduces the prevalence of BPD ([@B7]). The association of deficiency of vitamin A and RA with impaired growth and development of both the diaphragm and the lung highlights these molecules as potential options for therapeutic and preventive intervention to reduce the severity of diaphragmatic and respiratory impairment in preterm infants.

We hypothesized that the diaphragm of preterm neonates was susceptible to dysfunction associated with MV. We further hypothesized that supplementation of ventilated preterm lambs with a combination of vitamin A and all-*trans* retinoic acid (VARA) would counteract the detrimental effects of MV on the diaphragm and thereby reduce the severity of VIDD. Therefore, the present study aimed to establish the impact of MV on fiber composition, protein signaling, proteolytic activity, and tissue oxidation of preterm lambs, and to identify the impact of enteral VARA on these outcomes.

Materials and Methods {#s1}
=====================

Animal Management and Study Design
----------------------------------

The animal experiments were approved by the Institutional Animal Care and Use Committee at the University of Utah, Health Sciences Center (IACUC11-11002). Breeding, ewe-management and postnatal lamb ventilation followed protocols described previously. ([@B26]; [@B1]; [@B15]) Briefly, time-mated ewes received intramuscular antenatal dexamethasone (6 mg; Vedco, Inc., St. Joseph, MO, United States) 24 h prior to planned surgical delivery at 130--132 days of gestation (term∼150 days). Preterm lambs were assigned randomly to four groups: (1) Fetal Start (130--132 days) and (2) Fetal End (133--135 days), (3) MV; (4) MV with Aquasol A palmitate 2500 IU/kg/day (Pfizer, United States) and all-*trans* retinoic acid 250 IU/kg/day (MV + VARA). VARA was diluted in canola oil and given orogastrically, beginning immediately after delivery and repeated at 24 h intervals. Plasma retinol was measured by quantitative HPLC (ARUP Lab, Salt Lake City, UT, United States).

Preterm fetal lambs were killed (Beuthanasia solution 100 mg/kg, i.v., Schering-Plough Animal Health Corporation, Union, NJ, United States) either immediately on exteriorisation prior to commencement of breathing (fetal reference groups one and two) or after 3 days of postnatal management and MV as described below (groups three and four). The left costal hemidiaphragm was harvested immediately after euthanasia and snap frozen (-80°C) for biochemical and molecular experiments ([@B34]).

Mechanical Ventilation Protocol
-------------------------------

Preterm lambs in the MV and MV + VARA groups were intubated, using a cuffed endotracheal tube (3.5--4.0 French) through which 10 mL of lung liquid was aspirated and replaced with beractant (4 mL, NDC 0074-1040-08; Ross Products Division, Abbott Laboratories, Columbus, OH, United States). Each fetus was then removed from the uterus before its umbilical cord was ligated and cut.

Preterm lambs were managed by pressure-limited, synchronized intermittent mandatory ventilation, with warmed and humidified 100% oxygen (Bird VIP ventilator, model 15215; Bird Products Corporation, CA, United States). Arterial blood gasses, pH, electrolytes, and glucose were measured hourly, using an indwelling arterial catheter in the right common carotid artery. Oxygen saturation was monitored by pulse oximetry (target was 90--94%). Vascular pressures and heart rate were recorded continuously (model V6400; SurgiVet, Waukesha, WI, United States). Dextrose was infused intravenously to maintain plasma glucose level between 60 and 90 mg/dl. Plasma concentrations of total protein and hematocrit were measured at 6 h intervals. Lambs received intermittent postnatal sedation, postnatal antibiotics and graduated incremental enteral feeding as tolerated, in accordance with previous studies ([@B15]).

Initial respiratory rate was 60 breaths/min and inspiratory time was 0.3 s. Peak inspiratory pressure (PIP) was adjusted to attain a target *P*a~CO2~ between 45 and 60 mm Hg and pH between 7.25 and 7.35. Positive end-expiratory pressure (PEEP) was initially set at 8 cm H~2~O. Target expiratory tidal volume, measured by the ventilator, was 5--7 mL/kg/breath. The concentration of inspired O~2~ was adjusted to target a *P*a~O2~ between 60 and 80 mm Hg. Target Pa~O2~ and Pa~CO2~ were reached within 1--2 h of postnatal life. All of the preterm lambs received an intravenous loading dose of caffeine citrate within 30 min of delivery to stimulate ventilatory drive (15 mg/kg, given over 2 h; Mead Johnson and Co., Evansville, IN, United States), followed by maintenance treatment with 5 mg/kg every 24 h ([@B15]).

Isolation of mRNA and Quantitative Real Time RT-PCR
---------------------------------------------------

RNA purification, reverse transcription, and quantitative real time RT-PCR were performed ([@B36]). The primers of MHC gene (*MHC neonatal*, *MHC I*, *MHC IIa*, *MHC IIb*, and *MHC IIx*) were designed to target specific coding sequences of MHC isoforms (**Table [1](#T1){ref-type="table"}**). The method of expression assay for the atrophic genes (*MAFbx* and *MuRF1*), cytokine genes (*IL-1*β and *IL-6*), antioxidant genes (*glutathione peroxidase 1*, *GPX1*; *superoxide dismutase 1*, *SOD1*, and *catalase*), as described previously ([@B36]; [@B34],[@B35]). Fluorescence signal was analyzed and normalized against 18S RNA, which was constant amongst groups. Relative expression levels were calculated, using the 2^-ΔΔCT^ method. Results are presented as fold-change relative to the Fetal Start unventilated reference group.

###### 

Primer sequences for MHC isoforms.

  Gene             Primer sequence (5′-3′)     Accession No. (GenBank)   Product size (bp)
  ---------------- --------------------------- ------------------------- -------------------
  *MHC neonatal*   F CCTACTGCTTCGTGGCTGACT     XM_004012708              107
                   R CACCAGCGTCCTGTTGTCT                                 
  *MHC I*          F AGGACGTCTTTGTGCCTGATGA    XM_004010325              107
                   R GGTCACTGTCTTGCCATGC                                 
  *MHC IIa*        F ATCTGTCTTTGTGGCCGAGC      XM_004012707              106
                   R TGTCAGAGTCGCCCCTCCT                                 
  *MHC IIb*        F CAAAGAGAAGCATGTTATCTTTC   XM_004012705              161
                   R TAGACGTGCCTTCTGGGCTGA                               
  *MHC IIx*        F TGGCCAGCAACATGGAGACT      XM_004012706              147
                   R GACGTGCTCTCTGAGTTGTT                                
                                                                         

F, forward; R, reverse; MHC, myosin heavy chain.

Muscle Protein Extraction and Western Blot Analysis
---------------------------------------------------

Cytosolic and nuclear proteins were isolated, as described previously ([@B37]). Protein concentration was measured, using the Bradford method (Sigma, Sydney, Australia). Twenty μg protein samples were resolved on 4--15% TGX Stain-Free gels (Bio-Rad, Gladesville, NSW, Australia) and protein was transferred onto nitrocellulose membrane, using a Trans Turbo Blot system (Bio-Rad). Western blotting was done with primary antibodies for phosphorylated (p)-Akt (Ser473) (9271), total Akt (9272), p-mTOR (Ser2448) (2971), total mTOR (2983), p-p70S6 Kinase (Thr389) (9234), total p70S6 Kinase (2708), p-4E-BP1 (Thr70) (9455), total 4E-BP1 (9452), FOXO1 (9454), and NF-κB p65 (3987) from Cell Signaling Technology (Carlsbad, CA, United States). The primary antibodies were dissolved in phosphate-buffered saline containing 0.1% Tween-20 (PBST) and 0.5% skimmed milk in 1:2000 dilutions and added to the membranes at 4°C overnight. Bound antibodies were detected, using anti rabbit immunoglobulin conjugated with horseradish peroxidase (7074, Cell Signaling Technology). The secondary antibody was used in 1:3000 in PBST with 0.5% skimmed milk and incubated with membranes at room temperature for 1 h. After adding a chemiluminescent substrate (Thermo Fisher Scientific, MA, United States), immunoreactive protein signals were detected and quantified, using ChemiDoc MP Imaging System (Bio-Rad). The activities of cytoplasmic signaling molecules are shown as phosphorylated/total protein ratio. The value for nuclear FOXO1 and NF-κB content was normalized to total nuclear protein content of the same lane on the blot.

Biochemical Analysis of Proteasome Activity and Oxidative Stress
----------------------------------------------------------------

The chymotrypsin-like peptidase activity of the 20S proteasome was measured fluorometrically in crude extracts using a commercial kit (BML-AK740 assay kit, Enzo Life Sciences, NY, United States). Protein carbonyl level was measured in cell lysates, using Protein Carbonyl Colorimetric Assay Kit (Cayman Chemical, Ann Arbor, MI, United States).

Data Analysis
-------------

SigmaPlot (version 12.0, Systat Software Inc, San Jose, CA, United States) was used for statistical analysis. Differences among multiple groups were assessed, using one-way ANOVA, with a Tukey honestly significant difference (HSD) test for *post hoc* analysis. Non-parametric data were analyzed, using ANOVA on ranks. The Pearson correlation index was calculated to determine association among different variables, using linear regression analysis. We assessed statistical significance at *p* \< 0.05. Data are presented as mean (SD) or median (range). There were no differences in oxygenation (PaO~2~/FiO~2~ or oxygenation index (OI) despite initial increased PaO~2~ and mean airway pressure (MAP) in the VARA group (**Table [3](#T3){ref-type="table"}**).

Results
=======

Lamb Characteristics
--------------------

Descriptive characteristics for each group are presented in **Table [2](#T2){ref-type="table"}**. No statistically significant differences were detected for gestational age, body weight, and sex at birth amongst the groups. Final weight was not different between the MV and MV + VARA groups of preterm lambs. Mean (SD) plasma retinol was increased in the MV + VARA group \[0.087 (0.019) mg/L\] compared to the MV group \[0.065 (0.006) mg/L\] (*p* = 0.021).

###### 

Descriptive characteristics for the lambs used in the experimental study.

  Group                      Fetal start   Fetal end     MV            MV + VARA
  -------------------------- ------------- ------------- ------------- -------------
  N                          7             7             10            6
  GA                         130--132      135--136      130--132      130--132
  Sex (M:F)                  3:4           3:4           5:5           6:0
  Ewe parity (Twin:Single)   7:0           2:5           4:6           3:3
  Birth weight               3.58 (0.71)   3.02 (0.44)   3.95 (0.63)   4.16 (0.62)
  Final weight               N/A           N/A           3.77 (0.74)   3.83 (0.64)
                                                                       

GA, gestational age; N/A, not determined; MV, mechanical ventilation; VARA, vitamin A and all-

trans

retinoic acid.

###### 

Postnatal respiratory variables.

  Variable              Time (h)   MV            MV + VARA     *p*-value
  --------------------- ---------- ------------- ------------- -----------
  FiO~2~ (%)                                                   
                        24         27 (10)       37 (22)       0.152
                        48         28 (9)        30 (7)        0.271
                        72         28 (10)       32 (15)       0.938
  PaO~2~ (mm Hg)                                               
                        24         73 (11)       91 (25)^∗^    0.042
                        48         84 (12)       84 (11)       0.699
                        72         78 (11)       69 (9)        0.083
  O~2~ Saturation (%)                                          
                        24         95 (2)        95 (3)        0.855
                        48         96 (2)        95 (2)        0.519
                        72         95 (3)        94 (2)        0.250
  PIP (cmH~2~O)                                                
                        24         16 (3)        19 (5)        0.212
                        48         19 (3)        21 (4)        0.206
                        72         19 (3)        21 (3)        0.189
  MAP (cmH~2~O)                                                
                        24         11 (1)        13 (1)^∗^     0.025
                        48         12 (1)        12 (2)        0.981
                        72         12 (1)        12 (1)        0.895
  pH                                                           
                        24         7.33 (0.07)   7.32 (0.04)   0.733
                        48         7.32 (0.04)   7.29 (0.06)   0.171
                        72         7.34 (0.08)   7.38 (0.09)   0.326
  PaCO~2~ (mm Hg)                                              
                        24         46 (6)        54 (13)       0.124
                        48         51 (8)        55 (8)        0.438
                        72         53 (6)        52 (14)       0.179
  PaO~2~/FiO~2~                                                
                        24         299 (80)      281 (139)     0.793
                        48         348 (139)     339 (114)     0.437
                        72         296 (96)      265 (161)     0.519
  OI                                                           
                        24         2.46 (1.10)   3.18 (2.06)   0.313
                        48         2.45 (1.30)   3.02 (0.78)   0.364
                        72         2.79 (1.67)   3.52 (3.48)   0.606
                                                               

MV, mechanical ventilation; VARA, vitamin A all-

trans

-retinoic acid; FiO

2

, fractional inspired oxygen; PaO

2

, arterial partial pressure of oxygen; PIP, peak inspiratory pressure; MAP, mean airway pressure; PaCO

2

, arterial partial pressure of carbon dioxide; OI, oxygenation Index \[FiO

2

× 100 × MAP/(PaO

2

× 1.36)\]. Values are mean (SD) or median (IQR) for parametric and non-parametric variables, respectively.

MHC mRNA Levels
---------------

Five MHC isoforms were quantified for differences in mRNA level in the diaphragm (**Figure [1](#F1){ref-type="fig"}**). Baseline *MHC IIb* mRNA level was very low and therefore its level was unreliable for quantification. Changes in MHC isoform mRNA levels were similar between the MV and MV + VARA groups. MV for 3 days reduced *MHC neonatal*, *MHC I*, and *MHC IIa* mRNA levels compared to unventilated Fetal Start and Fetal End reference groups, irrespective of VARA treatment. Conversely, 3 days of MV significantly increased mRNA level of *MHC IIx* in the MV group compared to both control groups.

![MHC molecules. Graphs show *MHC neonatal* **(A)**, *MHC I* **(B)**, *MHC IIa* **(C)**, and *MHC IIx* **(D)** mRNA levels in the groups of Fetal Start (*n* = 7), Fetal End (*n* = 7), MV (*n* = 10), and MV + VARA (*n* = 6). mRNA levels are expressed as fold-change relative to Fetal Start group. Boxes show are Median (25th and 75th centile), whiskers (error bars) show 10th, 90th centiles with solid circles showing outliers. ^∗^indicates *p* \< 0.05, while ^∗∗^indicates *p* \< 0.001. MHC, myosin heavy chain; MV, mechanical ventilation; VARA, vitamin A and all-*trans* retinoic acid.](fphys-09-01119-g001){#F1}

Protein Degradation
-------------------

The activity of the principal proteolytic pathway (ubiquitin proteasome pathway, UPP) was measured as a marker of proteolysis. Three days of MV significantly increased diaphragmatic level of UPP activity by 84% (**Figure [2A](#F2){ref-type="fig"}**). Daily VARA treatment significantly lowered proteolytic activity compared to the MV group (**Figure [2A](#F2){ref-type="fig"}**).

![Proteolytic molecules. Graphs show 20S proteasome activity **(A)** and atrophic gene *MuRF1* **(B)** and *MAFbx* **(C)** mRNA levels in the groups of Fetal Start (*n* = 6/7), Fetal End (*n* = 6/7), MV (*n* = 9/10), and MV + VARA (*n* = 6). Values are Mean (SD) for 20S proteasome activity or Median (25th and 75th centile) for mRNA level data, expressed as fold-change relative to Fetal Start group. ^∗^indicates *p* \< 0.05. MV, mechanical ventilation; VARA, vitamin A and all-*trans* retinoic acid.](fphys-09-01119-g002){#F2}

We also quantified the mRNA level of two key components of the 20S proteasome pathway (MuRF1 and MAFbx). *MuRF1* mRNA level increased significantly in the diaphragm of the MV group compared to both unventilated fetal reference groups (*p* \< 0.05). Treatment with VARA prevented the MV induced increase in *MuRF1* mRNA level (*p* \< 0.05, **Figure [2B](#F2){ref-type="fig"}**) to a level not different from either unventilated fetal gestational reference group. *MAFbx* mRNA level was not significantly different between the four experimental groups (**Figure [2C](#F2){ref-type="fig"}**), although the pattern of changes were the same as for *MuRF1*. As expected, UPP activity correlated significantly correlated with mRNA level of *MuRF1* (*r* = 0.785, *p* \< 0.001, **Supplementary Data Sheet [1](#SM1){ref-type="supplementary-material"}**).

Molecular Signaling and Inflammatory Responses
----------------------------------------------

We also investigated several key intracellular mediators of anabolic (Akt, mTOR, p70S6K, and 4E-BP1) and catabolic (FOXO1 and NF-κB) pathways to identify effects on signal transduction cascades.

Three days of MV alone did not change protein abundance in the diaphragm of any of the four measured anabolic pathway mediators (**Figure [3](#F3){ref-type="fig"}**). MV + VARA decreased the abundance of phosphorylated cytosolic 4E-BP1 compared to the MV group (**Figure [3D](#F3){ref-type="fig"}**). The level of phosphorylated cytosolic 4E-BP1 was not different among the MV+VARA and unventilated fetal reference groups.

![Cytosolic signaling molecules. Western blots illustrate protein abundance of signaling molecules in cytosolic fraction, using representative samples from each group above the graphs. Graphs show p-Akt/total Akt protein **(A)**, p-mTOR/total mTOR protein **(B)**, p-p70S6/ total p70S6 kinase **(C)**, and p-4E-BP1/total 4E-BP1 protein **(D)** in the groups of Fetal Start (*n* = 5), Fetal End (*n* = 5), MV (*n* = 5), and MV + VARA (*n* = 6). p: phosphorylated. Values are Mean (SD). ^∗^Indicates *p* \< 0.05. MV, mechanical ventilation; VARA, vitamin A and all-*trans* retinoic acid.](fphys-09-01119-g003){#F3}

For the two markers of catabolic pathways, neither nuclear FOXO1 nor NF-κB protein abundance were affected by 3 days of MV compared to both unventilated fetal reference groups (**Figure [4](#F4){ref-type="fig"}**). Protein abundance of nuclear FOXO1 was reduced in the MV + VARA group compared to the MV group (*p* \< 0.05, **Figure [4B](#F4){ref-type="fig"}**).

![Nuclear FOXO1 and NF-κB. Western blots illustrate protein abundance of signaling molecules in nuclear fraction, using representative samples from each group **(A)**. Graphs show nuclear FOXO1 **(B)** and NF-κB **(C)** protein abundance in the groups of Fetal Start (*n* = 5), Fetal End (*n* = 5), MV (*n* = 5), and MV + VARA (*n* = 6). Values are Mean (SD). ^∗^indicates *p* \< 0.05. MV, mechanical ventilation; VARA, vitamin A and all-*trans* retinoic acid.](fphys-09-01119-g004){#F4}

mRNA expression levels of the inflammatory markers IL-1β and IL-6 were not different between the MV and MV + VARA groups of preterm lambs (**Figure [5](#F5){ref-type="fig"}**).

![Inflammatory cytokines. Graphs show mRNA level of *IL-1*β **(A)** and *IL-6* **(B)** in the groups of Fetal Start (*n* = 6), Fetal End (*n* = 6), MV (*n* = 7), and MV + VARA (*n* = 6). Values are Median (25th and 75th centile), expressed as fold-change relative to Fetal Start group. Values are Mean (SD). ^∗^indicates *p* \< 0.05. MV, mechanical ventilation; VARA, vitamin A and all-*trans* retinoic acid.](fphys-09-01119-g005){#F5}

Oxidative Stress and Antioxidant Gene Expression
------------------------------------------------

Protein carbonyl formation is a measure of oxidative stress and a general indicator of protein oxidation. Diaphragmatic protein carbonyl abundance increased in the MV group compared to the unventilated Fetal Start reference group (*p* \< 0.05, **Figure [6](#F6){ref-type="fig"}**). The increase in abundance of protein carbonyl in mechanically ventilated lambs was prevented by treatment with VARA (*p* \< 0.05, **Figure [6](#F6){ref-type="fig"}**). Changes in protein carbonyl abundance correlated positively with the change observed in UPP activity (*r* = 0.722, *p* \< 0.001) and mRNA level of *MuRF1* (*r* = 0.574, *p* \< 0.01) (**Supplementary Data Sheet [1](#SM1){ref-type="supplementary-material"}**).

![Protein carbonyl abundance. Graphs show protein carbonyl abundance in diaphragm of Fetal Start (*n* = 6), Fetal End (*n* = 7), MV (*n* = 9), and MV + VARA (*n* = 6) groups. Values are Mean (SD). ^∗^indicates *p* \< 0.01. MV, mechanical ventilation; VARA, vitamin A and all-*trans* retinoic acid.](fphys-09-01119-g006){#F6}

We also analyzed mRNA expression levels of three antioxidant genes: glutathione peroxidase 1 (*GPX1)*, superoxide dismutase 1 (*SOD1), and catalase*. *SOD1* mRNA level was significantly lower in the diaphragm of the MV group compared to the Fetal-End unventilated reference group (**Figure [7B](#F7){ref-type="fig"}**). No effect of MV or treatment with VARA was evident on the mRNA expression levels of *GPX1* (**Figure [7A](#F7){ref-type="fig"}**) or catalase (**Figure [7C](#F7){ref-type="fig"}**) genes.

![Antioxidant mRNA levels. Graphs show *GPX1* **(A)**, *SOD1* **(B)**, and *catalase* **(C)** mRNA levels in the groups of Fetal Start (*n* = 7), Fetal End (*n* = 7), MV (*n* = 10), and MV + VARA (*n* = 6). Values are Median (25th and 75th centile), expressed as fold-change relative to Fetal Start group. ^∗^indicates *p* \< 0.05. GPX1, glutathione peroxidase 1; SOD1, superoxide dismutase 1; MV, mechanical ventilation; VARA, vitamin A and all-*trans* retinoic acid.](fphys-09-01119-g007){#F7}

Discussion
==========

We show that postnatal MV for 3 days disrupts MHC mRNA levels, activates the UPP protein degradation pathway, and promotes oxidative stress in the diaphragm of preterm lambs. Daily VARA treatment during 3 days of mechanical does not affect MHC mRNA expression levels. However, daily treatment with VARA significantly decreases activation of the proteolytic pathway and prevents oxidative stress induced by MV.

These are the first experiments to evaluate the biological effects of MV on molecular signaling in the preterm neonatal diaphragm. Increased proteolysis and oxidative stress in diaphragms of ventilated preterm lambs supports the supposition that preterm infants may be susceptible to VIDD. Remodeling and atrophy of muscle fibers is a key feature of VIDD and accounts for inability to wean adults from MV to unassisted spontaneous breathing ([@B33]; [@B41]). The underlying mechanisms governing muscle fiber changes are probably associated with both pre-translational and post-translational regulations ([@B41]; [@B31]; [@B32]). In adults, diaphragmatic levels of MHC mRNA exhibit little change during the first 18 h of MV ([@B32]), whereas MHC mRNA levels are altered over the subsequent 30 h, leading to a slow-to-fast shift in MHC protein expression in the diaphragm ([@B41]). However, such muscle fiber composition transition cannot be extrapolated simply to the preterm lamb model due to the different composition of muscle fiber type in the immature diaphragm. Our study shows that mRNA expression levels of genes for the predominant fiber types (MHC IIa and I) are significantly lower in the diaphragm of preterm lambs after 3 days of MV compared to unventilated Fetal-End reference lambs, which match the postconceptional age of the preterm lambs after 3 days of ventilation support. Meanwhile, MV reduced *MHC neonatal* mRNA level and increased *MHC IIx* mRNA level. These results need to be interpreted alongside what is known about fiber type development in the lamb diaphragm. Fiber composition analysis in naïve lamb diaphragm at 121 or 127 days of gestation shows that the predominantly expressed isoform is MHC Type IIa (67%) with MHC Type I representing 15% of the total fibers ([@B6]; [@B34]). Subsequently, a decrease in MHC Type IIb/x, and an almost complete loss of neonatal MHC mRNA level occurs from late gestation to term ([@B6]). Given the relative proportion of MHC isoforms in the preterm diaphragm, reduced levels of *MHC IIa and MHC I* mRNA after 3 days of MV may contribute to total MHC protein loss. Thus, altered conformations or reduced absolute numbers of contractile proteins may decrease the number of cross-bridges available to generate force, resulting in functional deficit.

The effect of MV on MHC mRNA expression levels may not be the major contributing factor for muscle atrophy in our study. Other studies show that diaphragmatic atrophy and contractile dysfunction occur as early as 12--18 h after onset of MV, accompanied by activation of the proteolytic pathway ([@B33]; [@B19]). Atrophy and contractile dysfunction are exacerbated during longer periods of MV ([@B32]; [@B9]). Thus, the functional and phenotypic changes in diaphragm are mainly attributable to accelerated protein degradation, along with reduction of anabolic pathways ([@B33], [@B32]; [@B22], [@B25]), which precedes MHC mRNA change. During MV, diaphragmatic protein breakdown occurs through the degradation of myofibrillar proteins via the ATP-dependent ubiquitin proteasome pathway (UPP). The UPP pathway is regulated transcriptionally through atrophy genes (*MAFbx* and *MuRF1*), as evidenced by the positive association between UPP activity and *MuRF1* mRNA level in the present and previous studies ([@B9]). Our data show that 3 days of MV activates the UPP system and induces up-regulation of *MuRF1* mRNA level in our preterm lamb model. Together, these findings support our hypothesis that MV increases protein degradation in the diaphragm of preterm lambs, possibly leading to atrophy and subsequently muscle weakness.

Up-regulation of *MAFbx* and *MuRF1* genes is governed by transcriptional factors FOXO1 and NF-κB during disuse muscle atrophy ([@B23]; [@B5]). However, we show that nuclear FOXO1 and NF-κB content remain constant after 3 days of MV. Accordingly, the upstream regulators, Akt signaling and cytokines (IL-1β and IL-6), for FOXO1 and NF-κB, respectively, are not altered in response to MV. We may exclude, therefore, a principal role of the FOXO1 and NF-κB pathways in initiating UPP activation in our preterm MV model. Alternative mechanisms, such as regulation of atrophy-related genes via JNK, AMPK, FOXO3, TRAF6, and Smads, may exist ([@B5]). Apart from inhibiting nuclear translocation of FOXO, Akt activates its downstream effectors (p70S6K and 4E-BP1) to drive protein synthesis through mTOR. From our analysis of this anabolic signaling cascade, we did not identify an effect of MV on the protein synthesis pathway in this study, although cannot exclude the possibility of a Type II statistical error.

Mechanical ventilation is associated with rapid onset of oxidative stress in the adult diaphragm, occurring within 3--6 h of initiating MV ([@B42]). Similarly, our study shows that 3 days of MV increases diaphragmatic protein carbonyl formation by approximately threefold. There is increasing evidence to implicate ROS accumulation with oxidative stress as an atrophic signaling trigger \[*i.e.*, ROS activates FOXO and induces atrophic genes, leading to UPP activation ([@B24]); ROS augments calcium-dependent protease, calpain, and caspase-3 activity ([@B33]; [@B39]; [@B24])\]. Independent of accelerated proteolysis, ROS has direct deleterious effects on muscle contractile function by altering myofibrillar Ca^2+^ sensitivity and cross-bridge kinetics ([@B2]).

We also aimed to assess the benefit of enteral vitamin A supplementation on the occurrence and severity of VIDD in preterm lambs. We used a combination of vitamin A and all-*trans* retinoic acid (VARA) because this mixture provides substrate for formation of bioactive retinoids, through retinyl esters ([@B28]). VARA treatment is effective for reducing severity of bronchopulmonary dysplasia in a hyperoxic rat model and is absorbed via the enteral route, providing an alternative to intramuscular administration. Treatment of rat pups with VARA, for example, increased retinyl esters and improved alveolar formation more than vitamin A alone ([@B29]; [@B27]; [@B30]). We used an optimized retinol dosage of 2500 IU/Kg/day, given orogastrically in a 10:1 ratio with all-trans retinoic acid. We based dosage optimization on efficacy to promote alveolar formation, without evidence of elevated liver enzymes. The advantage of orogastric delivery is that it eliminates pain and stress caused by daily intramuscular injection, which is otherwise required for vitamin A supplementation. Retinoic acid, the active metabolite of vitamin A, binds to retinoic acid and retinoic X receptors when transported to the nucleus. These heterodimeric pairs recruit a range of coactivators or corepressors to regulate gene transcription and influence protein production. However, our results show that VARA does not promote transcriptional upregulation of MHC mRNAs during MV.

Our results show that daily enteral VARA attenuates the UPP pathway (lower 20S proteasome activity and *MuRF1* mRNA level), the protein catabolic pathway (lower FOXO1 protein level), and oxidative stress pathway (lower protein carbonyl formation) over 3 days of MV. In particular, our data show that accelerated protein degradation during MV is restored to normal level after VARA. We suggest, therefore, that VARA treatment reduces protein catabolism of the diaphragm of preterm lambs during MV. The decrease in UPP is likely due to down-regulation of atrophic gene *MuRF1* through reduced FOXO1 signaling.

The effect of VARA in preventing VIDD is also supported by the important evidence that VARA treatment reverses ventilator-induced oxidative stress in the diaphragm of preterm lambs. Reduced oxidative stress may explain the decrease in FOXO1 signaling and the resulting decrease in proteolytic activity during VARA treatment. This mechanistic link is supported by other studies ([@B33]; [@B24]) and the significant association between protein carbonyl level and UPP activity/*MuRF1* mRNA level identified in the present study.

Cellular redox potential is maintained by balanced regulation of pro-oxidative and anti-oxidative enzymes. GPX proteins along with SOD and catalase are part of the enzymatic defense system that cells use to reduce free radical-mediated cellular injury. Vitamin A deficiency leads to lower GSH/GSSG ratio in rat liver ([@B3]), less activity of glutathione-S-transferase in lung ([@B12]), and less lung SOD and catalase ([@B11]). An antioxidant mechanism of vitamin A may be attributed to transcriptional regulation of antioxidant genes. To test this hypothesis, we examined GPX1, SOD1, and catalase transcripts over the experimental period. Our data show that daily VARA treatment during 3 days of MV does not reduce *GPX1, SOD1*, or *catalase* mRNA levels. However, we should not exclude the possibility that other antioxidant genes are regulated by retinoic acid. For example, recently Haddad and colleagues identified *GPX3* as a primarily retinoid-responsive gene that mediates the antioxidative effects of retinoic acid in human skeletal muscle cell ([@B14]). Alternatively, the antioxidant activity of retinoic acid may be due to the hydrophobic chain of polyene units, which quench singlet oxygen, neutralize thiol radicals, and stabilize and combine with peroxyl radicals ([@B21]).

Our study has some weaknesses. We note that there is a potential difference in sex distribution between MV + VARA group (constituted of six male lambs) and other groups, although we did not observe a statistical significance due to low sample size. However, preterm male fetuses usually show poorer respiratory, hemodynamic and neurodevelopmental responses than female counterparts. Hence, the male dominance of the MV+VARA group may have reduced the magnitude of the beneficial effect of VARA on reducing the impact of MV on the diaphragm ([@B40]; [@B4]). We also acknowledge that whilst the changes in biochemical and molecular markers of the diaphragm are consistent with damage resulting from MV, we cannot confirm that MV was the cause of this dysfunction. Keeping preterm lambs alive for 3 days without any MV is not achievable using the current model and hence fetal lambs at starting and end gestations were used to account for the effect of maturation. Nonetheless, these fetal lambs have not been exposed to other postnatal managements including nutrition, antibiotics, caffeine and oxygen. Finally the study is limited in that we lack of direct evidence in relation to change of diaphragm function and structure and protein turnover, particularly how passive ventilation stimulates change of contractile properties of the diaphragms in preterm model. Contractile measurements are not feasible due to the geographical separation of the collaborating groups and lack of appropriate muscle function expertise in the preterm lamb laboratory group.

Conclusion
==========

Three days of MV impairs the preterm diaphragm via abnormal expression of myofibrillar composition, activation of proteases, and oxidative injury. Daily administration of VARA for 3 days attenuates catabolic signaling, probably by protecting cells from oxidative stress. We suggest that enteral VARA may be a promising therapeutic target for maintenance of muscle protein balance in preterm infants at risk of VIDD.
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BPD

:   bronchopulmonary dysplasia

GA

:   gestational age.

GPX1

:   glutathione peroxidase 1

HSD

:   honestly significant difference

MHC

:   myosin heavy chain

MV

:   mechanical ventilation

p

:   phosphorylated

PEEP

:   positive end-expiratory pressure

PIP

:   peak inspiratory pressure

RA

:   retinoic acid

ROS

:   reactive oxygen species

SOD1

:   superoxide dismutase 1

UPP

:   ubiquitin proteasome pathway

VARA

:   vitamin A and all-*trans* retinoic acid

VIDD

:   ventilator-induced diaphragmatic dysfunction
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